Results

Total Results: 581 records

Showing results for "Grade D Cancer".

  1. effectivehealthcare.ahrq.gov/products/cognitive-decline/research-protocol
    March 23, 2016 - Additionally, dementia-related expenses exceed those for other diseases, including heart disease and cancer … associated with an increased risk of developing MCI and Alzheimer's disease, including depression, cancer … - Social engagement Network, social activities Vitamin supplements Multivitamins, vitamin DD. … Atkins D, Chang S, Gartlehner G, et al.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/behavior-change_research.pdf
    August 01, 2015 - Key Informants Appendix D. … published, strength of evidence methodology for qualitative research, CerQUAL, was presented at a recent GRADE … Enhancing the use and quality of colorectal cancer screening. … 1 Appendix D. … D-2 Interview Guide 1.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
    May 08, 2013 - Research Review Citation: Chou R, Dana T, Bougatsos C, Blazina I, Starmer A, Reitel K, Buckley D. … The NPUAP has now adopted the term "Stage" rather than "Grade". … The first (BMJ) is listed in Appendix D as excluded because ""Wrong Population"". … Also there is no grade V. … evaluation of screening tools, distinguishes between screening for disease detection such as breast cancer
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
    March 11, 2010 - history of thyroid disease, Down’s syndrome and treatment with external beam radiation for head and neck cancer … Chest pain d. Increased blood pressure e. Anxiety f. Depression g. Insomnia h. Nausea i. … Abnormal hair loss d. Upset stomach or nausea e. Loss of taste or metallic taste f. … Interventions (dose, duration) , Control, Outcomes assessed/when assessed, Adverse effects, Results D. … In: Fauci A, Braunwald E, Kasper D, Houser S, Longo D, Jameson J, editors.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plant-based-chronic-pain-review-q2.pdf
    May 01, 2021 - Dowell D, Haegerich TM, Chou R. … Dowell D, Haegerich TM, Chou R. … D-1 Appendix D. Literature Flow Diagram Figure D-1. … Takakuwa KM, Sulak D. … Yassin M, Oron A, Robinson D.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - renal artery aneurysm requiring repair, aortic disease requiring invasive intervention, or concurrent cancer … Only RCTs could receive an A grade. … Hanzel G, Balon H, Wong O, Soffer D, Lee DT, Safian RD. … Harjai K, Khosla S, Shaw D et al. … Ramos F, Kotliar C, Alvarez D et al.
  7. effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician
    February 16, 2016 - Owens DK, Lohr KN, Atkins D, et al. … Oral: 666 mg (two 333-mg tablets) 3 times per day Modulates hyperactive glutamatergic n-methyl-d-aspartate … consistently related heavy alcohol consumption to an increased risk of serious health problems such as cancer
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - * Owens DK, Lohr KN, Atkins D, et al. … Oral: 666 mg (two 333-mg tablets) 3 times per day Modulates hyperactive glutamatergic n-methyl-d-aspartate … consistently related heavy alcohol consumption to an increased risk of serious health problems such as cancer
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-jan-2020.pdf
    January 01, 2020 - Dowell D, Haegerich TM, Chou R. … Dowell D, Haegerich TM, Chou R. … Turcotte D, Doupe M, Torabi M, et al. … D-1 Appendix D. Literature Flow Diagram Figure D-1. … Yassin M, Oron A, Robinson D.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - 3 pain In Bhatla, 2010, 20.5% of the HPV group and 4.0% of the placebo group reported Grade 3 pain … The table results reflect death categorized as noncardiovasuclar, cancer and other. … TEP # 4 Executive Summary— Results, Table D (and Table 32), Page 21, line 22 Table D (and Table … Does grade refer to the severity rating system described in the methods? … In J Gyn Cancer. 2008;18:1013-9 Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - 3 pain In Bhatla, 2010, 20.5% of the HPV group and 4.0% of the placebo group reported Grade 3 pain … The table results reflect death categorized as noncardiovasuclar, cancer and other. … TEP # 4 Executive Summary— Results, Table D (and Table 32), Page 21, line 22 Table D (and Table … Does grade refer to the severity rating system described in the methods? … In J Gyn Cancer. 2008;18:1013-9 Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta
  12. effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol
    April 02, 2015 - For healthy adults, AIs for ALA are 1.1 g/d for females and 1.6 g/d for males. 16 After evaluating evidence … attacks) Exclude populations chosen for having a non-CVD or non-diabetes-related disease (e.g., cancerD. … Grading the Strength of Evidence We will grade the strength of the body of evidence as per the AHRQ … FAs and different populations [healthy, at risk, and with CVD]) Outcome Strength of Evidence Grade
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/preoperative-testing_executive.pdf
    January 01, 2014 - find some abnormal test results that will lead to new diagnoses (such as previously undetected lung cancer … a n d s tr en g th o f ev id en ce O u tc o m e Su rg er y Te st s St u d y D es ig … s St u d y D es ig n (R is k o f B ia s) Fi n d in g St re n g th o f Ev id en ce … s St u d y D es ig n (R is k o f B ia s) Fi n d in g St re n g th o f Ev id en ce … ( 1 hi gh ) N o si gn ifi ca nt d if fe re nc e in p ro ce du re d el ay .
  14. effectivehealthcare.ahrq.gov/sites/default/files/introduction.ppt
    January 01, 2010 - References: Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al. … quality of individual studies Assess applicability Present findings Synthesize quantitative data Grade … References References Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/introduction.ppt
    January 01, 2010 - References: Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al. … quality of individual studies Assess applicability Present findings Synthesize quantitative data Grade … References References Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-approaches_research.pdf
    June 01, 2011 - the study is not a mega-trial) precluding an answer to the Key Question (resulting in an evidence grade … Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review … BMC Cancer 2009;9:451. PMID: 20021637 9. Abbas S, Seitz M. … self-regulation from published prospective controlled cohort studies for long-term therapy of breast cancer … non-randomized comparative studies of the short-term outcomes of laparoscopic resection for colorectal cancer
  17. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
    June 01, 2012 - Studies Analyze and Synthesize Studies Assess Risk of Bias as a Domain of Quality Assess Applicability Grade … Screening for Cervical Cancer. … results to treatment not reported Order of testing varies across subjects and was not randomly assigned D-dimer … Screening for Cervical Cancer. … likely to have false-positive screenings under current recommendations because of the risks of high-grade
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
    June 01, 2012 - Studies Analyze and Synthesize Studies Assess Risk of Bias as a Domain of Quality Assess Applicability Grade … Screening for Cervical Cancer. … results to treatment not reported Order of testing varies across subjects and was not randomly assigned D-dimer … Screening for Cervical Cancer. … likely to have false-positive screenings under current recommendations because of the risks of high-grade
  19. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - cardiometabolic syndrome, hypertension, stroke, sleep apnea, osteoarthritis, gall bladder disease, and some cancers … , grade II at 62.12%, and grade III at 51.44%, (p<0.0001). … However, no link between liraglutide and thyroid C-cell tumors, including a thyroid cancer called medullary … used in patients with a personal or family history of MTC or in patients with multiple endocrine neoplasia … Wilding J, Lau D, Astrup A, et al.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ischemic-stroke-treatment_research-protocol.pdf
    February 19, 2010 - of Ischemic Stroke Stroke is the third leading cause of death following diseases of the heart and cancer … Effectiveness outcomes will include: recanalization as measured by post-TIMI flow grade (0/1=no recanalization … D. … Lloyd-Jones D, Adams R, Carnethon M et al. … Thrombectomy N/A TriSpan Endovascular Thrombectomy N/A Phenox GmbH Lise-Meitner-Allee 31 D-

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: